Literature DB >> 25963903

Targeting of miR9/NOTCH1 interaction reduces metastatic behavior in triple-negative breast cancer.

Samira Mohammadi-Yeganeh1,2, Ardalan Mansouri2, Mahdi Paryan3,4.   

Abstract

Many reports have indicated deregulation of a variety of microRNAs (miRNAs) in human cancers. In this study, we appraised miR-9 correlation with NOTCH1 involved in Notch signaling in metastatic breast cancer. The Notch signaling pathway has been approved to be associated with the development and progression of many human cancers, including breast cancer, but the precise mechanism has remained unknown. To the best of our knowledge, this is the first study that introduces miR-9 and NOTCH1 correlation as an effective factor in breast cancer. We found that miR-9 expression was decreased in MDA-MB-231 breast cancer cells compared with MCF-10A normal breast cell line. However, NOTCH1 was upregulated in the metastatic breast cancer cells. Furthermore, luciferase assay revealed a significant inverse correlation between miR-9 and NOTCH1. Overexpression of Notch signaling via Notch1 intracellular domain in MDA-MB-231 cell line was suppressed by lentiviruses expressing miR-9. Taken together, the results obtained by MTT, flow cytometry, migration, and wound healing assays showed that it is possible to inhibit metastasis and induce pro-apoptotic state by induction of miR-9 expression in MDA-MB-231 cells but with no effect on cell proliferation. These results shows that miR-9, by direct targeting of NOTCH1, can reveal a suppressor-like activity in metastatic breast cancer cells.
© 2015 John Wiley & Sons A/S.

Entities:  

Keywords:  MDA-MB-231; NOTCH1; Notch signaling; breast cancer; miR-9

Mesh:

Substances:

Year:  2015        PMID: 25963903     DOI: 10.1111/cbdd.12584

Source DB:  PubMed          Journal:  Chem Biol Drug Des        ISSN: 1747-0277            Impact factor:   2.817


  18 in total

1.  MicroRNA-9 rescues hyperglycemia-induced endothelial cell dysfunction and promotes arteriogenesis through downregulating Notch1 signaling.

Authors:  Huang Chen; Zhihai Feng; Lieyou Li; Lin Fan
Journal:  Mol Cell Biochem       Date:  2021-03-15       Impact factor: 3.396

Review 2.  Anti-miRNA oligonucleotides: A comprehensive guide for design.

Authors:  Joana Filipa Lima; Laura Cerqueira; Ceu Figueiredo; Carla Oliveira; Nuno Filipe Azevedo
Journal:  RNA Biol       Date:  2018-03-23       Impact factor: 4.652

Review 3.  The role of epigenetic modifications in drug resistance and treatment of breast cancer.

Authors:  Mohsen Karami Fath; Ali Azargoonjahromi; Arash Kiani; Fateme Jalalifar; Parisa Osati; Mahsa Akbari Oryani; Fateh Shakeri; Farhad Nasirzadeh; Behman Khalesi; Mohsen Nabi-Afjadi; Hamidreza Zalpoor; Maysam Mard-Soltani; Zahra Payandeh
Journal:  Cell Mol Biol Lett       Date:  2022-06-28       Impact factor: 8.702

4.  Chrysophanol suppresses growth and metastasis of T cell acute lymphoblastic leukemia via miR-9/PD-L1 axis.

Authors:  Junjie Yin; Qingsong Yin; Bo Liang; Ruihua Mi; Hao Ai; Lin Chen; Xudong Wei
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-12-14       Impact factor: 3.000

Review 5.  MicroRNAs, a Promising Target for Breast Cancer Stem Cells.

Authors:  Plabon Kumar Das; Mst Ayesha Siddika; Saharia Yeasmin Asha; Suraiya Aktar; Md Abdur Rakib; Jahan Ara Khanam; Suja Pillai; Farhadul Islam
Journal:  Mol Diagn Ther       Date:  2020-02       Impact factor: 4.074

Review 6.  Prognostic role of miR-9 expression in various human malignant neoplasms: a meta-analysis.

Authors:  Xiaodan Liu; Ziyan Luo; Hongxia Peng; Hua Jiang; Ling Xu
Journal:  Onco Targets Ther       Date:  2016-05-23       Impact factor: 4.147

Review 7.  Mechanistic Pathways of Malignancy in Breast Cancer Stem Cells.

Authors:  Saghar Yousefnia; Farzad Seyed Forootan; Shiva Seyed Forootan; Mohammad Hossein Nasr Esfahani; Ali Osmay Gure; Kamran Ghaedi
Journal:  Front Oncol       Date:  2020-04-30       Impact factor: 6.244

8.  Reciprocal Regulation between Bifunctional miR-9/9(∗) and its Transcriptional Modulator Notch in Human Neural Stem Cell Self-Renewal and Differentiation.

Authors:  Beate Roese-Koerner; Laura Stappert; Thomas Berger; Nils Christian Braun; Monika Veltel; Johannes Jungverdorben; Bernd O Evert; Michael Peitz; Lodovica Borghese; Oliver Brüstle
Journal:  Stem Cell Reports       Date:  2016-07-14       Impact factor: 7.765

Review 9.  The versatile nature of miR-9/9* in human cancer.

Authors:  Katarzyna Nowek; Erik A C Wiemer; Mojca Jongen-Lavrencic
Journal:  Oncotarget       Date:  2018-04-17

10.  Screen for MicroRNA and Drug Interactions in Breast Cancer Cell Lines Points to miR-126 as a Modulator of CDK4/6 and PIK3CA Inhibitors.

Authors:  Federica Baldassari; Carlotta Zerbinati; Marco Galasso; Fabio Corrà; Linda Minotti; Chiara Agnoletto; Maurizio Previati; Carlo M Croce; Stefano Volinia
Journal:  Front Genet       Date:  2018-05-18       Impact factor: 4.772

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.